Diabetes Mellitus, Type 2: all 9,590 studies

Page 31 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.

• Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in YouthCompletedNCT00413335Not applicableResults posted
• A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)CompletedNCT00411554Phase 3Results posted
• Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 DiabetesCompletedNCT00411411Phase 3Results posted
• Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 DiabetesCompletedNCT00401622Not applicableResults posted
• Initial Combination With Pioglitazone Study (0431-064)CompletedNCT00397631Phase 3Results posted
• Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00395746Phase 3Results posted
• Sitagliptin Added-on to Insulin Study (0431-051)CompletedNCT00395343Phase 3Results posted
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00393718Phase 3Results posted
• Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)CompletedNCT00393705Phase 4Results posted
• Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)CompletedNCT00392678Phase 2/3Results posted
• A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®CompletedNCT00391027Phase 4Results posted
• A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminCompletedNCT00386100Phase 4Results posted
• Insulin Glargine "All to Target" TrialCompletedNCT00384085Phase 4Results posted
• RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesCompletedNCT00379769Phase 3Results posted
• Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)CompletedNCT00377858Phase 4Results posted
• Safety and Tolerability Study of Cycloset in Treatment of Type 2 DiabetesCompletedNCT00377676Phase 3Results posted
• Effect on Weight Loss of Exenatide Versus PlaceboCompletedNCT00375492Phase 3Results posted
• A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00374907Phase 3Results posted
• Study Of GW823093 In Japanese Subjects With Type 2 Diabetes MellitusCompletedNCT00372957Phase 2Results posted
• MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)CompletedNCT00372060Phase 3Results posted
• Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 DiabetesCompletedNCT00367055Phase 4Results posted
• The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 DiabetesTerminatedNCT00366301Phase 4Results posted
• Insulin Glulisine in Type 2 Diabetic PatientsCompletedNCT00360698Phase 4Results posted
• A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes PatientsCompletedNCT00360334Phase 3Results posted
• Exenatide Versus Glimepiride in Patients With Type 2 DiabetesCompletedNCT00359762Phase 3Results posted
• A Pilot Study of BMS-512148 in Subjects With Type 2 DiabetesCompletedNCT00357370Phase 2/3Results posted
• The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 DiabetesCompletedNCT00353834Phase 4Results posted
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)CompletedNCT00350779Phase 3Results posted
• Effect of Androgel on Type 2 Diabetic Males With HypogonadismCompletedNCT00350701Phase 4Results posted
• Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaCompletedNCT00344370Phase 3Results posted
• The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy VolunteersCompletedNCT00339833Phase 4Results posted
• Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT00337610Phase 3Results posted
• Telerehabilitation Intervention to Promote Exercise for DiabetesCompletedNCT00334113Not applicableResults posted
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 DiabetesCompletedNCT00332488Phase 3Results posted
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular RiskCompletedNCT00330733Phase 2/3Results posted
• Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00328627Phase 3Results posted
• Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes PatientsCompletedNCT00328172Phase 2Results posted
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic NephropathyCompletedNCT00324675Not applicableResults posted
• The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 DiabetesCompletedNCT00321321Phase 2Results posted
• 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 DiabetesCompletedNCT00318656Phase 4Results posted
• To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherCompletedNCT00318461Phase 3Results posted
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaCompletedNCT00309751Phase 3Results posted
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 DiabetesCompletedNCT00309608Phase 2Results posted
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-upCompletedNCT00309244Phase 3Results posted
• Safety of Inhaled Insulin With Type 1 and Type 2 DiabetesCompletedNCT00308737Phase 3Results posted
• Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)CompletedNCT00308139Phase 3Results posted
• Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)CompletedNCT00305604Phase 3Results posted
• Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)CompletedNCT00296296Phase 4Results posted
• A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneCompletedNCT00295633Phase 3Results posted
• Moderate Alcohol Intake Among Patients With Type 2 DiabetesCompletedNCT00295334Phase 2Results posted
• To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cTerminatedNCT00294723Phase 3Results posted
• MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)CompletedNCT00289848Phase 3Results posted
• Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00286494Phase 3Results posted
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory ControlTerminatedNCT00283049Phase 4Results posted
• A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes MellitusTerminatedNCT00282971Phase 3Results posted
• The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)CompletedNCT00279201Phase 4Results posted
• A Study In Patients With Type 2 Diabetes MellitusCompletedNCT00256867Phase 3Results posted
• Empowering Patients to Better Manage Diabetes Through Self-CareCompletedNCT00254501Phase 3Results posted
• A Study Comparing Standard Care for Diabetes to Case-managed Care for Diabetes in Patients With Coronary Artery DiseaseCompletedNCT00248352Not applicableResults posted
• Preservation of Beta-cell Function in Type 2 Diabetes MellitusCompletedNCT00232583Not applicableResults posted
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesCompletedNCT00229658Results posted
• Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes MellitusCompletedNCT00225277Phase 3Results posted
• Actos Now for Prevention of Diabetes (ACT NOW)CompletedNCT00220961Phase 3Results posted
• Changes in Adiposity, Metabolic Measures From Atypicals to AripiprazoleCompletedNCT00205660Phase 4Results posted
• Preferred Treatment of Type 1.5 DiabetesCompletedNCT00194896Not applicableResults posted
• Hyperglycemia and Cardiovascular Outcomes With Type 2 DiabetesCompletedNCT00191282Phase 4Results posted
• Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 DiabetesCompletedNCT00184600Phase 3Results posted
• The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in HumansCompletedNCT00179400Phase 4Results posted
• Free Fatty Acids and Vascular Function in Subjects With DiabetesCompletedNCT00153179Phase 1/2Results posted
• Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 DiabetesCompletedNCT00147745Phase 2Results posted
• Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes MellitusTerminatedNCT00143247Phase 2Results posted
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy TrialCompletedNCT00141453Phase 3Results posted
• An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00135330Phase 3Results posted
• Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)CompletedNCT00131664Phase 3Results posted
• A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)CompletedNCT00127192Phase 2Results posted
• Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic PatientsCompletedNCT00123643Phase 4Results posted
• Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 DiabetesCompletedNCT00123604Phase 4Results posted
• Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneCompletedNCT00121667Phase 3Results posted
• Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00121641Phase 3Results posted
• Diabetes Telemedicine Consultation: A Systems Improvement InterventionCompletedNCT00119041Not applicableResults posted
• A New Oral Treatment For Type II Diabetes MellitusCompletedNCT00111800Phase 2Results posted
• Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic NephropathyTerminatedNCT00108485Phase 3Results posted
• Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)CompletedNCT00106704Phase 3Results posted
• MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)CompletedNCT00103857Phase 3Results posted
• Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular ComplicationsCompletedNCT00097786Phase 3Results posted
• Effects of Exenatide and Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00097500Phase 3Results posted
• An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)CompletedNCT00095056Phase 3Results posted
• An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)CompletedNCT00094770Phase 3Results posted
• An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)CompletedNCT00094757Phase 3Results posted
• Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)CompletedNCT00087516Phase 3Results posted
• Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)CompletedNCT00086515Phase 3Results posted
• Pioglitazone Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT00086502Phase 3Results posted
• Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and MetforminCompletedNCT00082407Phase 3Results posted
• Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and MetforminCompletedNCT00082381Phase 3Results posted
• Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)CompletedNCT00081328Phase 3Results posted
• The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)CompletedNCT00069784Phase 3Results posted
• Diabetes Prevention Program Outcomes StudyCompletedNCT00038727Phase 3Results posted
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)CompletedNCT00032487Phase 3Results posted
• Bypass Angioplasty Revascularization Investigation in Type 2 DiabetesCompletedNCT00006305Phase 3Results posted
• Action to Control Cardiovascular Risk in Diabetes (ACCORD)CompletedNCT00000620Phase 3Results posted

← Diabetes Mellitus, Type 2 overview